The "multiple production buildings in reserve to deal with such contingencies (fire accidents)” will ensure that production of their Covid-19 vaccine Covishield "won’t be hit,” noted Serum Institute of India (SII) chief executive officer Adar Poonawalla as reported in mid-day (MD) dated January 22, 2021. A "major fire” that engulfed their under-construction unit in Manjri, Poona had resulted in five persons, reportedly contract workers, perishing in the blaze the previous day. The unit is a short distance away from the facility where Covishield is manufactured under an arrangement with Oxford University and pharmaceutical company AstraZeneca. The Times of India of......